  A deterministic model with testing of infected individuals has been proposed
to investigate the potential consequences of the impact of testing strategy.
The model exhibits global dynamics concerning the disease-free and a unique
endemic equilibrium depending on the basic reproduction number when the
recruitment of infected individuals is zero; otherwise, the model does not have
a disease-free equilibrium, and disease never dies out in the community. Model
parameters have been estimated using the maximum likelihood method with respect
to the data of early COVID-19 outbreak in India. The practical identifiability
analysis shows that the model parameters are estimated uniquely. The
consequences of the testing rate for the weekly new cases of early COVID-19
data in India tell that if the testing rate is increased by 20% and 30% from
its baseline value, the weekly new cases at the peak are decreased by 37.63%
and 52.90%; and it also delayed the peak time by four and fourteen weeks,
respectively. Similar findings are obtained for the testing efficacy that if it
is increased by 12.67% from its baseline value, the weekly new cases at the
peak are decreased by 59.05% and delayed the peak by 15 weeks. Therefore, a
higher testing rate and efficacy reduce the disease burden by tumbling the new
cases, representing a real scenario. It is also obtained that the testing rate
and efficacy reduce the epidemic's severity by increasing the final size of the
susceptible population. The testing rate is found more significant if testing
efficacy is high. Global sensitivity analysis using partial rank correlation
coefficients (PRCCs) and Latin hypercube sampling (LHS) determine the key
parameters that must be targeted to worsen/contain the epidemic.
